Yeager R A, Porter J M
Oregon Health Sciences University School of Medicine, USA.
Adv Surg. 1996;29:33-9.
The perception that there is an expanding role for conservative management of patients with aortic graft infection is unfounded. There is,in fact, a striking paucity of convincing data indicating that outcome following nonresectional therapy for aortic prosthetic graft infection is equivalent to modern-day results utilizing extra-anatomic bypass and graft excision. Drainage with localized antibiotic irrigation and biologic coverage may be attempted in unusual circumstances such as the unfortunate patient with an infected thoracoabdominal aortic graft, in whom graft excision is not feasible. A truly noteworthy development in the treatment of aortic graft infection over the past decade has been the remarkable improvement in results utilizing remote bypass and standard excisional therapy with perioperative mortality and amputation rates less than 10%. In our opinion this approach remains the best and safest option.
认为主动脉移植物感染患者的保守治疗作用正在扩大这种看法是没有根据的。事实上,令人信服的数据极为匮乏,表明针对主动脉人工血管感染的非切除疗法的效果等同于采用解剖外旁路和移植物切除的现代治疗结果。在诸如感染胸腹主动脉移植物的不幸患者这类特殊情况下,若移植物切除不可行,可尝试进行局部抗生素冲洗引流及生物覆盖。在过去十年中,主动脉移植物感染治疗方面一个真正值得注意的进展是,采用远端旁路和标准切除疗法取得了显著改善,围手术期死亡率和截肢率均低于10%。我们认为这种方法仍然是最佳且最安全的选择。